Bioxyne Ltd
ASX:BXN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.005
0.026
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bioxyne Ltd
Bioxyne Ltd
Accounts Receivables
Bioxyne Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bioxyne Ltd
ASX:BXN
|
Accounts Receivables
AU$978.4k
|
CAGR 3-Years
43%
|
CAGR 5-Years
5%
|
CAGR 10-Years
20%
|
|
|
McPherson's Ltd
ASX:MCP
|
Accounts Receivables
AU$24m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-9%
|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Accounts Receivables
AU$4.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Elixinol Wellness Ltd
ASX:EXL
|
Accounts Receivables
AU$1.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Accounts Receivables
AU$2.9m
|
CAGR 3-Years
57%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hydration Pharmaceuticals Co Ltd
ASX:HPC
|
Accounts Receivables
$1.7m
|
CAGR 3-Years
30%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Bioxyne Ltd
Glance View
Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The firm operates through two segments wholesale sales and direct sales. The firm manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The firm is focusing on developing a range of functional food and beauty products.
See Also
What is Bioxyne Ltd's Accounts Receivables?
Accounts Receivables
978.4k
AUD
Based on the financial report for Jun 30, 2024, Bioxyne Ltd's Accounts Receivables amounts to 978.4k AUD.
What is Bioxyne Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
20%
Over the last year, the Accounts Receivables growth was 18%. The average annual Accounts Receivables growth rates for Bioxyne Ltd have been 43% over the past three years , 5% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet